The magic of sodium-glucose cotransporter-2 inhibitors (SGLT2-i) – Benefits in metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2D)

Karen Cheuk-Ying Ho; Lung-Yi Mak

doi:10.3350/cmh.2025.1433

Articles

Page Path

Editorial

The magic of sodium-glucose cotransporter-2 inhibitors (SGLT2-i) – Benefits in metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2D)

Karen Cheuk-Ying Ho¹, Lung-Yi Mak^1,2

DOI: https://doi.org/10.3350/cmh.2025.1433 [Accepted]

Published online: January 6, 2026

¹Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong
²State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong

Corresponding author: Lung-Yi Mak, Tel: +852 28162863,
Email: loeymak@gmail.com

Received: 16 December 2025 • Accepted: 26 December 2025

399 Views
44 Download
0 Crossref
0 Scopus

Full Article

Download PDF

Citations

Citations to this article as recorded by

Cite

CITE

export

Copy Download

Format

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

The magic of sodium-glucose cotransporter-2 inhibitors (SGLT2-i) – Benefits in metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2D)

DOI: https://doi.org/10.3350/cmh.2025.1433

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
bib — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

The magic of sodium-glucose cotransporter-2 inhibitors (SGLT2-i) – Benefits in metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2D)

DOI: https://doi.org/10.3350/cmh.2025.1433

Articles

Page Path

The magic of sodium-glucose cotransporter-2 inhibitors (SGLT2-i) – Benefits in metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2D)

Full Article

Citations

CITE

Download Citation

Format:

Include:

Related articles

ABOUT

BROWSE ARTICLES

FOR CONTRIBUTORS